These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38969086)

  • 1. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy.
    Sharma V; Khokhar M; Panigrahi P; Gadwal A; Setia P; Purohit P
    Clin Chim Acta; 2024 Jul; 561():119842. PubMed ID: 38969086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in diabetic nephropathy: Unveiling novel biomarkers for diagnosis (Review).
    Luo Y; Zhang W; Qin G
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
    Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
    Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
    Darmayanti S; Lesmana R; Meiliana A; Abdulah R
    Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging.
    Wang Z; Fu W; Huo M; He B; Liu Y; Tian L; Li W; Zhou Z; Wang B; Xia J; Chen Y; Wei J; Abliz Z
    Acta Pharm Sin B; 2021 Nov; 11(11):3665-3677. PubMed ID: 34900545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry.
    Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ
    J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
    Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
    Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal medicine for the treatment of diabetic nephropathy: From clinical evidence to potential mechanisms.
    Gong XX; Cao LH; Ni HX; Zang ZY; Chang H
    J Ethnopharmacol; 2024 Aug; 330():118179. PubMed ID: 38636575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients.
    Yang J; Liu D; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():830466. PubMed ID: 35399949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.
    Peng L; Sun B; Liu Y; Huang J; Chen G; Zhang X; Chen C; Wang D; Wang G
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):679-685. PubMed ID: 33605471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.
    Wang J; Yan W; Zhou X; Liu Y; Tang C; Peng Y; Liu H; Sun L; Xiao L; He L
    PeerJ; 2020; 8():e9111. PubMed ID: 32461830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
    Roointan A; Gheisari Y; Hudkins KL; Gholaminejad A
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2253-2272. PubMed ID: 34059383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy.
    Shao M; Lu H; Yang M; Liu Y; Yin P; Li G; Wang Y; Chen L; Chen Q; Zhao C; Lu Q; Wu T; Ji G
    Ann Transl Med; 2020 Mar; 8(5):199. PubMed ID: 32309346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial activity contributes to impaired renal metabolic homeostasis and renal pathology in STZ-induced diabetic mice.
    Wu M; Li S; Yu X; Chen W; Ma H; Shao C; Zhang Y; Zhang A; Huang S; Jia Z
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F593-F605. PubMed ID: 31268353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study.
    Trifonova OP; Maslov DL; Balashova EE; Lichtenberg S; Lokhov PG
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422065
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.